Creative Bioarray
Creative Bioarray is a private biotechnology company that supplies cell biology products (primary cells, tumor lines, stem cells, FISH probes) and contract research services (DMPK, toxicology, histology, disease models) to pharmaceutical, biotech, academic, and cell/gene therapy researchers worldwide.
- Company typePrivate
- Founded2011
- HeadquartersNew York, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Creative Bioarray does
Creative Bioarray is a privately-held biotechnology company that supplies cell biology products and contract research services to pharmaceutical, biotechnology, academic, and cell/gene therapy customers. The company's catalog spans over 2,000 primary cell lines (human and animal, 17 species), 1,500+ tumor cell lines, iPSCs, mesenchymal and pluripotent stem cells, immortalized cells, biosamples, ADME kits, stains/dyes, and proprietary FISH/ISH probes (marketed under the CABR™ brand). Underlying technologies include 3D spheroid and organoid culture, cell immortalization via epigenetic induction, GMP-grade cytokine manufacturing (ActoFactor™), and validated disease model portfolios (CDX, PDX, syngeneic) for preclinical drug development.
The company operates five specialized platform brands that function as semi-autonomous business units: Cell Culture Platform (cytokines, bioprocessing media, custom media), Electrophysiology Platform (acroscell, ion channel screening), Histopathology Platform (histobiolab), Drug Discovery Platform (DMPK, toxicology, safety pharmacology, animal models), and FISH Platform (ChromoGenetics, cell line characterization and gene therapy biodistribution). These are supported by sub-brands including QualiCell® for qualified stem cells and PremSera® for tumor culture sera.
Creative Bioarray generates revenue through two primary streams: (1) direct e-commerce sales of catalog products (cells, probes, kits, biosamples) priced on a per-unit or quote basis, and (2) fee-for-service contract research across cell services, histology, DMPK/ADME, safety toxicology, disease modeling, and FISH-based biodistribution analysis. Distribution is handled via direct sales through five platform-specific websites plus a global distributor network. The company maintains offices in the United States and Germany, with a stated footprint of 80,000+ customers served and 23,000+ cases completed.
Creative Bioarray firmographics
Firmographics- Name
- Creative Bioarray
- Legal name
- Creative Bioarray
- Website
- https://creative-bioarray.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Creative Bioarray is a private biotechnology company that supplies cell biology products (primary cells, tumor lines, stem cells, FISH probes) and contract research services (DMPK, toxicology, histology, disease models) to pharmaceutical, biotech, academic, and cell/gene therapy researchers worldwide.
- Ownership category
- akta.pro rank
Creative Bioarray industry classification
Industry- Product category
- Biomedical research reagents and preclinical contract research services
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation) (HLAAAIAI)
- akta.pro secondary industry
- Protein Interaction & Structural Biology Platforms (cryo-EM, X-ray, NMR, biophysics) (HLAAAIAH)
Keywords
Where Creative Bioarray is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Creative Bioarray business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Cell and Biosample Products: Sale of primary cells, stem cells, tumor cell lines, immortalized cells, biosamples (tissue sections, FFPE blocks, blood products), FISH/ISH probes, assay kits, stains, dyes, and ADME screening kits. Products are sold directly via e-commerce with standard per-unit pricing.
- Contract Research Services: Fee-for-service preclinical research services including cell services, histology, DMPK/ADME studies, safety toxicology testing, disease model studies, stem cell research services, and FISH analysis. Services billed by project or assay type.
- Custom Product Development: Custom cell line development, custom probe design, and custom media formulation services for specific research requirements.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Creative Bioarray product offering
Product offeringCore offering
Creative Bioarray supplies life-science research communities with catalog biological products — including primary cells, tumor cells, stem cells, ISH/FISH probes, biosamples, and ADME kits — alongside contract research services spanning cell culture, electrophysiology, histopathology, drug discovery, and FISH analysis. Offerings support pharmaceutical, biotechnology, academic, and consumer-product organizations from target identification through preclinical characterization. The company combines product sales with project-based service engagements across five integrated technology platforms.
Product overview
Creative Bioarray is a biotechnology company offering a comprehensive portfolio of cell biology products and services for biomedical research. The product portfolio includes over 2,000 primary cell lines (human and animal), 1,500+ tumor cell lines, stem cells (iPSCs, mesenchymal, pluripotent), immortalized cells, ISH/FISH probes (CABR™ brand), biosamples, ADME kits, cell analysis kits, stains & dyes, and nucleic acid extraction products. These are complemented by five specialized service platforms: Cell Culture Platform (cytokines, bioprocessing media), Electrophysiology Platform (ion channel screening), Histopathology Platform, Drug Discovery Platform (ADME/DMPK, toxicology), and FISH Platform (cell line characterization, gene therapy analysis). The company provides end-to-end research solutions spanning from cell products to preclinical services including disease models, stem cell research, histology, and safety evaluation.
Differentiator
Problem solved
Functional benefit
Brands
- Cell Culture Platform: Specialized platform for cell culture, bioprocessing media, cytokines, cell therapy products, and custom media development services
- acroscell
- histobiolab
- Drug Discovery Platform
- ChromoGenetics
Products and services
- Primary Cells Catalog of primary cells isolated from healthy human and animal tissues, supplied to research scientists for in vitro studies, disease modeling, and assay development.
- Tumor Cells Catalog of tumor-derived cell lines used by oncology research groups for cancer biology studies, drug screening, and tumor model development.
- Stem Cells Stem cell products supplied for regenerative medicine, developmental biology, and cell therapy research applications.
- ISH/FISH Probes In-situ hybridization (ISH) and fluorescence in-situ hybridization (FISH) probe products for cytogenetic analysis, gene mapping, and chromosomal abnormality detection in research samples.
- Biosamples Human and animal biospecimens supplied for biomedical research, including tissue, blood, and biofluid samples with associated donor and clinical metadata.
- ADME Kits Ready-to-use absorption, distribution, metabolism, and excretion (ADME) assay kits used in preclinical drug metabolism and pharmacokinetic studies.
- Drug Discovery Services Contract drug discovery research services including assay development, screening, and lead characterization for pharmaceutical and biotechnology clients.
- Preclinical Research Services Preclinical in vivo and in vitro research services supporting efficacy, pharmacokinetic, and safety studies for early-stage therapeutic programs.
- Custom Cell Isolation Services Custom isolation and propagation of primary cells from healthy or diseased tissues tailored to a client's specific research protocol and tissue requirements.
- Electrophysiology Services Contract electrophysiology assays including microelectrode array and patch-clamp studies for cardiac safety, neuronal, and ion-channel drug profiling.
- Histopathology Services Histopathology and immunohistochemistry services, including tissue processing, staining, and microscopic analysis for preclinical and translational research programs.
- FISH Analysis Services Contract fluorescence in-situ hybridization (FISH) analysis services including probe selection, hybridization, and microscopic interpretation for cytogenetic and oncology studies.
Companies that use Creative Bioarray
Customer profileSegments4 records
Ideal customer profiles2 records
Creative Bioarray technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Creative Bioarray partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Creative Bioarray competitors and assessment
Company assessmentDirect peers
- PromoCell:
- ATCC: ATCC is the world's leading cell line and biological materials repository, offering primary cells, tumor cell lines, and biosamples directly comparable to Creative Bioarray's core catalog. Both target academic and pharma researchers with authenticated, quality-controlled cell products.
- Cell Applications Inc: Cell Applications is a direct competitor offering primary cells, cell culture reagents, and contract research services to academic and biotech researchers. Its product catalog and target customer base overlap closely with Creative Bioarray's core offerings.
- iXCells Biotechnologies: iXCells provides primary cells, iPSC services, and cell-based assay services to pharma and academic researchers. Its iPSC generation, disease modeling, and custom cell services overlap directly with Creative Bioarray's stem cell and drug discovery platforms.
Broad incumbents
- Lonza Bioscience: Lonza is a global CDMO and life science tools provider with extensive cell biology products, GMP cytokines, and cell therapy manufacturing capabilities. It competes with Creative Bioarray across cell products, GMP cytokines, and preclinical research services at significantly larger scale.
- Bio-Techne: Bio-Techne is a major life science tools company offering cytokines, antibodies, and cell biology reagents. It directly competes with Creative Bioarray's cytokine (ActoFactor™) and cell product lines while operating at much larger scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Creative Bioarray social profiles
Digital presenceCreative Bioarray financial estimates
Financial estimateRevenue estimate
Valuation estimate
Creative Bioarray leadership team
Management profileNumber of profiles
Creative Bioarray subsidiaries and ownership
Company hierarchySubsidiaries5 records
Creative Bioarray funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Creative Bioarray M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Creative Bioarray
What does Creative Bioarray do?
Creative Bioarray supplies life-science research communities with catalog biological products — including primary cells, tumor cells, stem cells, ISH/FISH probes, biosamples, and ADME kits — alongside contract research services spanning cell culture, electrophysiology, histopathology, drug discovery, and FISH analysis. Offerings support pharmaceutical, biotechnology, academic, and consumer-product organizations from target identification through preclinical characterization. The company combines product sales with project-based service engagements across five integrated technology platforms.
Is Creative Bioarray a public or private company?
Creative Bioarray is a private company. It is classified as unknown and is currently operating.
When was Creative Bioarray founded?
Creative Bioarray was founded in 2011. It employs 51 to 100 people.
Where is Creative Bioarray based?
Creative Bioarray is headquartered in New York, United States, in the North America region.
How does Creative Bioarray make money?
Three revenue lines are on record. Cell and Biosample Products are the primary driver. The others are contract Research Services and custom Product Development.
Who are Creative Bioarray's main competitors?
Direct peers on record are PromoCell, ATCC, Cell Applications Inc and iXCells Biotechnologies. Broad incumbents are Lonza Bioscience and Bio-Techne.
Does Creative Bioarray have an API?
No public API is recorded for Creative Bioarray.
What industry is Creative Bioarray in?
Creative Bioarray's product category is Biomedical research reagents and preclinical contract research services. Its primary akta.pro industry code is HLAAAIAI, Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation), with a secondary code of HLAAAIAH, Protein Interaction & Structural Biology Platforms (cryo-EM, X-ray, NMR, biophysics). Its NAICS code is 325414 and its SIC code is 8731.